At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Study to Evaluate the Impact of Using Interferon (Pegylated or Not) in the Treatment of Patients With Chronic Hepatitis C in Brazil (DECISION)
In Brief
An observational study evaluating Conventional Interferon, Peginterferon Alfa-2a, and 2 other interventions for Hepatitis C, Chronic. Completed, enrolled 660 participants across 37 sites.
Detailed Summary
This retrospective study will assess the sustained virologic response and the safety of two different interferons (pegylated or conventional) in patients with chronic hepatitis C. Data will be collected for 24 weeks.
Study Details
Timeline
Interventions
Conventional interferon according to the standard of care and aligned with the local prescription instructions
Peginterferon alfa-2a according to the standard of care and aligned with the local prescription instructions
Peginterferon alfa-2b according to the standard of care and aligned with the local prescription instructions
Ribavirin according to the standard of care and aligned with the local prescription instructions